Zacks.com on MSN
Why Merck's 32% Rally Isn't Enough to Change the Bearish View
MRK is up over 32% in three months, but declining estimates, Keytruda's upcoming LOE and Gardasil declines keep the stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback